Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-07-15

FDA Approved: PHOTREXA CROSS-LINKING KIT — Original Application (Glaukos Corporation)

View source ↗

Summary

The FDA approved Photrexa Cross-Linking Kit (riboflavin 5-phosphate ophthalmic) from Glaukos to perform corneal collagen cross-linking for slowing progression o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PHOTREXA CROSS-LINKING KIT (Riboflavin 5-phosphate ophthalmic)

Snippet

ORIG AP for PHOTREXA CROSS-LINKING KIT (RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC)